| Product NDC: | 68682-302 |
| Proprietary Name: | Pyridostigmine Bromide |
| Non Proprietary Name: | Pyridostigmine Bromide |
| Active Ingredient(s): | 60 mg/1 & nbsp; Pyridostigmine Bromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68682-302 |
| Labeler Name: | Oceanside Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA009829 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20071030 |
| Package NDC: | 68682-302-10 |
| Package Description: | 100 TABLET in 1 BOTTLE (68682-302-10) |
| NDC Code | 68682-302-10 |
| Proprietary Name | Pyridostigmine Bromide |
| Package Description | 100 TABLET in 1 BOTTLE (68682-302-10) |
| Product NDC | 68682-302 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pyridostigmine Bromide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20071030 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Oceanside Pharmaceuticals |
| Substance Name | PYRIDOSTIGMINE BROMIDE |
| Strength Number | 60 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |